Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics
An established forum for evidence-based clinical discussion, interdisciplinary dialogue, and patient considerationsEvent is expanded to two days, live and virtual on June 11-12, 2026, at the MaRS Discovery District, Toronto TORONTO, April 20, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.